Selected research
Industry Research
Hemostatic Powder Spray Industry Research Report 2026
Market perspective
The global Hemostatic Powder Spray market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hemostatic Powder Spray is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hemostatic Powder Spray is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hemostatic Powder Spray is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hemostatic Powder Spray include Medtronic, QuikClot, Pfizer Inc., Hemostasis, LLC, Ethicon Inc., EndoClot Plus, Inc, CryoLife, Inc., Cook Medical and BD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hemostatic Powder Spray market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hemostatic Powder Spray Market by Company
Medtronic
QuikClot
Pfizer Inc.
Hemostasis, LLC
Ethicon Inc.
EndoClot Plus, Inc
CryoLife, Inc.
Cook Medical
BD
Baxter International Inc.
B. Braun
Advanced Medical Solutions Group
Hemostatic Powder Spray Segment by Type
Less than 50ml
50ml and Above
Hemostatic Powder Spray Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
Hemostatic Powder Spray Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Powder Spray market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Powder Spray and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Powder Spray.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hemostatic Powder Spray manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hemostatic Powder Spray by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hemostatic Powder Spray in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Less than 50ml
- 50ml and Above
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Others
Companies covered
- Medtronic
- QuikClot
- Pfizer Inc.
- Hemostasis, LLC
- Ethicon Inc.
- EndoClot Plus, Inc
- CryoLife, Inc.
- Cook Medical
- BD
- Baxter International Inc.
- B. Braun
- Advanced Medical Solutions Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hemostatic Powder Spray Market Size (2021-2032)
- 2.2.2 Global Hemostatic Powder Spray Sales (2021-2032)
- 2.2.3 Global Hemostatic Powder Spray Market Average Price (2021-2032)
- 2.3 Hemostatic Powder Spray by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Less than 50ml
- 2.3.3 50ml and Above
- 2.4 Hemostatic Powder Spray by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Retail Pharmacy
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hemostatic Powder Spray Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hemostatic Powder Spray Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Hemostatic Powder Spray Revenue of Manufacturers (2021-2026)
- 3.4 Global Hemostatic Powder Spray Average Price by Manufacturers (2021-2026)
- 3.5 Global Hemostatic Powder Spray Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hemostatic Powder Spray, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hemostatic Powder Spray, Product Type & Application
- 3.8 Global Manufacturers of Hemostatic Powder Spray, Established Date
- 3.9 Global Hemostatic Powder Spray Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Hemostatic Powder Spray Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 QuikClot
- 4.2.1 QuikClot Company Information
- 4.2.2 QuikClot Business Overview
- 4.2.3 QuikClot Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 QuikClot Hemostatic Powder Spray Product Portfolio
- 4.2.5 QuikClot Recent Developments
- 4.3 Pfizer Inc.
- 4.3.1 Pfizer Inc. Company Information
- 4.3.2 Pfizer Inc. Business Overview
- 4.3.3 Pfizer Inc. Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Inc. Hemostatic Powder Spray Product Portfolio
- 4.3.5 Pfizer Inc. Recent Developments
- 4.4 Hemostasis, LLC
- 4.4.1 Hemostasis, LLC Company Information
- 4.4.2 Hemostasis, LLC Business Overview
- 4.4.3 Hemostasis, LLC Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hemostasis, LLC Hemostatic Powder Spray Product Portfolio
- 4.4.5 Hemostasis, LLC Recent Developments
- 4.5 Ethicon Inc.
- 4.5.1 Ethicon Inc. Company Information
- 4.5.2 Ethicon Inc. Business Overview
- 4.5.3 Ethicon Inc. Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ethicon Inc. Hemostatic Powder Spray Product Portfolio
- 4.5.5 Ethicon Inc. Recent Developments
- 4.6 EndoClot Plus, Inc
- 4.6.1 EndoClot Plus, Inc Company Information
- 4.6.2 EndoClot Plus, Inc Business Overview
- 4.6.3 EndoClot Plus, Inc Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 EndoClot Plus, Inc Hemostatic Powder Spray Product Portfolio
- 4.6.5 EndoClot Plus, Inc Recent Developments
- 4.7 CryoLife, Inc.
- 4.7.1 CryoLife, Inc. Company Information
- 4.7.2 CryoLife, Inc. Business Overview
- 4.7.3 CryoLife, Inc. Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CryoLife, Inc. Hemostatic Powder Spray Product Portfolio
- 4.7.5 CryoLife, Inc. Recent Developments
- 4.8 Cook Medical
- 4.8.1 Cook Medical Company Information
- 4.8.2 Cook Medical Business Overview
- 4.8.3 Cook Medical Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cook Medical Hemostatic Powder Spray Product Portfolio
- 4.8.5 Cook Medical Recent Developments
- 4.9 BD
- 4.9.1 BD Company Information
- 4.9.2 BD Business Overview
- 4.9.3 BD Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BD Hemostatic Powder Spray Product Portfolio
- 4.9.5 BD Recent Developments
- 4.10 Baxter International Inc.
- 4.10.1 Baxter International Inc. Company Information
- 4.10.2 Baxter International Inc. Business Overview
- 4.10.3 Baxter International Inc. Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Baxter International Inc. Hemostatic Powder Spray Product Portfolio
- 4.10.5 Baxter International Inc. Recent Developments
- 4.11 B. Braun
- 4.11.1 B. Braun Company Information
- 4.11.2 B. Braun Business Overview
- 4.11.3 B. Braun Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 B. Braun Hemostatic Powder Spray Product Portfolio
- 4.11.5 B. Braun Recent Developments
- 4.12 Advanced Medical Solutions Group
- 4.12.1 Advanced Medical Solutions Group Company Information
- 4.12.2 Advanced Medical Solutions Group Business Overview
- 4.12.3 Advanced Medical Solutions Group Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Advanced Medical Solutions Group Hemostatic Powder Spray Product Portfolio
- 4.12.5 Advanced Medical Solutions Group Recent Developments
5 Global Hemostatic Powder Spray Market Scenario by Region
- 5.1 Global Hemostatic Powder Spray Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hemostatic Powder Spray Sales by Region: 2021-2032
- 5.2.1 Global Hemostatic Powder Spray Sales by Region: 2021-2026
- 5.2.2 Global Hemostatic Powder Spray Sales by Region: 2027-2032
- 5.3 Global Hemostatic Powder Spray Revenue by Region: 2021-2032
- 5.3.1 Global Hemostatic Powder Spray Revenue by Region: 2021-2026
- 5.3.2 Global Hemostatic Powder Spray Revenue by Region: 2027-2032
- 5.4 North America Hemostatic Powder Spray Market Facts & Figures by Country
- 5.4.1 North America Hemostatic Powder Spray Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hemostatic Powder Spray Sales by Country (2021-2032)
- 5.4.3 North America Hemostatic Powder Spray Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hemostatic Powder Spray Market Facts & Figures by Country
- 5.5.1 Europe Hemostatic Powder Spray Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hemostatic Powder Spray Sales by Country (2021-2032)
- 5.5.3 Europe Hemostatic Powder Spray Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hemostatic Powder Spray Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hemostatic Powder Spray Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hemostatic Powder Spray Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hemostatic Powder Spray Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hemostatic Powder Spray Market Facts & Figures by Country
- 5.7.1 South America Hemostatic Powder Spray Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hemostatic Powder Spray Sales by Country (2021-2032)
- 5.7.3 South America Hemostatic Powder Spray Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hemostatic Powder Spray Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hemostatic Powder Spray Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hemostatic Powder Spray Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hemostatic Powder Spray Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hemostatic Powder Spray Sales by Type (2021-2032)
- 6.1.1 Global Hemostatic Powder Spray Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Hemostatic Powder Spray Sales Market Share by Type (2021-2032)
- 6.2 Global Hemostatic Powder Spray Revenue by Type (2021-2032)
- 6.2.1 Global Hemostatic Powder Spray Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hemostatic Powder Spray Revenue Market Share by Type (2021-2032)
- 6.3 Global Hemostatic Powder Spray Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hemostatic Powder Spray Sales by Application (2021-2032)
- 7.1.1 Global Hemostatic Powder Spray Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Hemostatic Powder Spray Sales Market Share by Application (2021-2032)
- 7.2 Global Hemostatic Powder Spray Revenue by Application (2021-2032)
- 7.2.1 Global Hemostatic Powder Spray Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hemostatic Powder Spray Revenue Market Share by Application (2021-2032)
- 7.3 Global Hemostatic Powder Spray Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hemostatic Powder Spray Value Chain Analysis
- 8.1.1 Hemostatic Powder Spray Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hemostatic Powder Spray Production Mode & Process
- 8.2 Hemostatic Powder Spray Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hemostatic Powder Spray Distributors
- 8.2.3 Hemostatic Powder Spray Customers
9 Global Hemostatic Powder Spray Analyzing Market Dynamics
- 9.1 Hemostatic Powder Spray Industry Trends
- 9.2 Hemostatic Powder Spray Industry Drivers
- 9.3 Hemostatic Powder Spray Industry Opportunities and Challenges
- 9.4 Hemostatic Powder Spray Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst